Nathan D. Grubaugh

Nathan D. Grubaugh

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Nathan D. Grubaugh

Yale School of Public Health 4 Department of Epidemiology of Microbial Diseases New Haven, CT

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2017 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JQJoshua Quick
Joshua Quick
NGNathan D Grubaugh
Nathan D Grubaugh
SPSteven T Pullan
Steven T Pullan
ICIngra M Claro
Ingra M Claro
ASAndrew D Smith
Andrew D Smith
NLNicholas J Loman
Nicholas J Loman

8 January 2019 in Genome Biology
Verified
Journal Article
Open access
PDF file
NGNathan D. Grubaugh
Nathan D. Grubaugh
KGKarthik Gangavarapu
Karthik Gangavarapu
JQJoshua Quick
Joshua Quick
NMNathaniel L. Matteson
Nathaniel L. Matteson
JJJaqueline Goes De Jesus
Jaqueline Goes De Jesus
KAKristian G. Andersen
Kristian G. Andersen
How viruses evolve within hosts can dictate infection outcomes; however, reconstructing this process is challenging. We evaluate our multiplexed amplicon approach, PrimalSeq, to demonstrate how virus concentration, sequencing coverage, primer mismatches, and replicates influence the accuracy of measuring intrahost virus diversity. We develop an experimental protocol and computational tool, iVar, for using PrimalSeq to measure virus diversity using Illumina and compare the results to Oxford Nanopore sequencing. We demonstrate the utility of PrimalSeq by measuring Zika and West Nile virus diversity from varied sample types and show that the accumulation of genetic diversity is influenced by experimental and biological systems.

18 September 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JPJordan Peccia
Jordan Peccia
AZAlessandro Zulli
Alessandro Zulli
DBDouglas E. Brackney
Douglas E. Brackney
NGNathan D. Grubaugh
Nathan D. Grubaugh
EKEdward H. Kaplan
Edward H. Kaplan
SOSaad B. Omer
Saad B. Omer

24 September 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
AWAnne L. Wyllie
Anne L. Wyllie
JFJohn Fournier
John Fournier
ACArnau Casanovas-Massana
Arnau Casanovas-Massana
MCMelissa Campbell
Melissa Campbell
MTMaria Tokuyama
Maria Tokuyama
AKAlbert I. Ko
Albert I. Ko
Rapid and accurate diagnostic tests are essential for controlling the ongoing Covid-19 pandemic. Although the current standard involves testing of nasopharyngeal swab specimens by quantitative reverse-transcriptase polymerase chain reaction (RT-qPCR) to detect SARS-CoV-2, saliva specimens may be an alternative diagnostic sample.1-4 Rigorous evaluation is needed to determine how saliva specimens compare with nasopharyngeal swab specimens with respect to sensitivity in detection of SARS-CoV-2 during the course of infection.

10 July 2020 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
CVChantal Vogels
Chantal Vogels
ABAnderson F. Brito
Anderson F. Brito
AWAnne L. Wyllie
Anne L. Wyllie
JFJoseph R. Fauver
Joseph R. Fauver
IOIsabel M. Ott
Isabel M. Ott
NGNathan D. Grubaugh
Nathan D. Grubaugh

24 May 2017 in Nature
Verified
Journal Article
Open access
PDF file
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
JQJ. Quick
J. Quick
ICI.M. Claro
I.M. Claro
JTJulien Thézé
Julien Thézé
JJJ. G. de Jesus
J. G. de Jesus
OPO. G. Pybus
O. G. Pybus
Virus genomes reveal the establishment of Zika virus in Brazil and the Americas, and provide an appropriate timeframe for baseline (pre-Zika) microcephaly in different regions. Three papers in this issue present a wealth of new Zika virus (ZIKV) genome sequences and further insights into the genetic epidemiology of ZIKV. Nathan Grubaugh et al. provide 39 new ZIKV genome sequences from infected patients and Aedes aegypti mosquitoes in Florida. Phylogenetic analysis suggests that the virus has been introduced on multiple separate occasions, probably linked to travel from the Caribbean. They find a low probability of long-term persistence of ZIKV transmission chains within Florida, suggesting that the potential for future ZIKV outbreaks there will depend on transmission dynamics in the Americas. Nuno Faria et al. and Hayden Metsky et al. reconstruct the spread of ZIKV in Brazil and the Americas. Faria et al. provide 54 new ZIKV genomes, several sequenced in real time in a mobile genomics laboratory. They trace the spatial origins and spread of ZIKV in Brazil and the Americas and date the timing of the international spread of ZIKV from Brazil. They find that northeast Brazil had a crucial role in the establishment of the epidemic and the spread of the virus within Brazil and the Americas. Metsky et al. generate 110 ZIKV genomes from clinical and mosquito samples from ten regions. They also see rapid expansion of the epidemic within Brazil and multiple introductions to other geographic areas. In agreement with Faria et al., they find that ZIKV circulated unobserved for many months before transmission was detected. Metsky et al. additionally describe ZIKV evolution and discuss how the accumulation of mutations might affect the performance of diagnostic tests in the future. Transmission of Zika virus (ZIKV) in the Americas was first confirmed in May 2015 in northeast Brazil1. Brazil has had the highest number of reported ZIKV cases worldwide (more than 200,000 by 24 December 20162) and the most cases associated with microcephaly and other birth defects (2,366 confirmed by 31 December 20162). Since the initial detection of ZIKV in Brazil, more than 45 countries in the Americas have reported local ZIKV transmission, with 24 of these reporting severe ZIKV-associated disease3. However, the origin and epidemic history of ZIKV in Brazil and the Americas remain poorly understood, despite the value of this information for interpreting observed trends in reported microcephaly. Here we address this issue by generating 54 complete or partial ZIKV genomes, mostly from Brazil, and reporting data generated by a mobile genomics laboratory that travelled across northeast Brazil in 2016. One sequence represents the earliest confirmed ZIKV infection in Brazil. Analyses of viral genomes with ecological and epidemiological data yield an estimate that ZIKV was present in northeast Brazil by February 2014 and is likely to have disseminated from there, nationally and internationally, before the first detection of ZIKV in the Americas. Estimated dates for the international spread of ZIKV from Brazil indicate the duration of pre-detection cryptic transmission in recipient regions. The role of northeast Brazil in the establishment of ZIKV in the Americas is further supported by geographic analysis of ZIKV transmission potential and by estimates of the basic reproduction number of the virus.